ReviewDiabetes, obesity & metabolism2026

Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease.

Amy K Mottl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.